Coffee consumption and nonalcoholic fatty liver onset: A prospective study in the general population

Translational Research

Volumn 165, Issue 3, 2015, Pages 428-436

  Zelber Sagi, Shira ^a   Salomone, Federico ^a,b   Webb, Muriel ^a   Lotan, Roni ^a   Yeshua, Hanny ^a   Halpern, Zamir ^a   Santo, Erwin ^a   Oren, Ran ^a   Shibolet, Oren ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Azienda Sanitaria Provinciale di Catania   (Italy)

Author keywords

Abbreviations; alanine aminotransferase; ALT; BMI; body mass index; FFQ; food frequency questionnaire; hepatorenal index; HOMA; homeostasis model assessment; HRI; NAFLD; NASH; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; ultrasonography; US

Indexed keywords

ADULT; ARTICLE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; FOOD INTAKE; HEPATORENAL INDEX; HUMAN; INTERVIEW; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER FUNCTION TEST KIT; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEATOTEST; STRUCTURED QUESTIONNAIRE; AGED; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; YOUNG ADULT;

COFFEE;

ADULT; AGED; COFFEE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84924500492     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.10.008     Document Type: Article

References (41)

1. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
2. M. Trauner, M. Arrese, and M. Wagner Fatty liver and lipotoxicity Biochim Biophys Acta 1801 2010 299 310
3. R. Gambino, G. Musso, and M. Cassader Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities Antioxid Redox Signal 15 2011 1325 1365
4. P. Dongiovanni, Q.M. Anstee, and L. Valenti Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment Curr Pharm Des 19 2013 5219 5238
5. S. Zelber-Sagi, V. Ratziu, and R. Oren Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence World J Gastroenterol 17 2011 3377 3389
6. A. Drewnowski, C.D. Rehm, and F. Constant Water and beverage consumption among adults in the United States: cross-sectional study using data from NHANES 2005-2010 BMC Public Health 13 2013 1068
7. S. Saab, D. Mallam, and G.A. Cox Ii et al. Impact of coffee on liver diseases: a systematic review Liver Int 34 2014 495 504
8. D. Catalano, G.F. Martines, and A. Tonzuso et al. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD) Dig Dis Sci 55 2010 3200 3206
9. J.W. Molloy, C.J. Calcagno, and C.D. Williams et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis Hepatology 55 2012 429 436
10. R. Anty, S. Marjoux, and A. Iannelli et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery J Hepatol 57 2012 1090 1096
11. K. Bambha, L.A. Wilson, and A. Unalp et al. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis Liver Int 34 2013 1250 1258
12. Nitzan Kaluski D, Goldsmith R, Chinitz A, et al. First National Health and Nutrition Survey, Part 2 1999-2001: Israel Center for Disease Control; 2004 October 2004. Report no.: Publication 218.
13. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
14. V. Ratziu, P. Giral, and F. Charlotte et al. Liver fibrosis in overweight patients Gastroenterology 118 2000 1117 1123
15. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
16. S. Zelber-Sagi, D. Nitzan-Kaluski, and Z. Halpern et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures Liver Int 26 2006 856 863
17. S. Zelber-Sagi, D. Nitzan-Kaluski, and Z. Halpern et al. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels J Hepatol 46 2007 700 707
18. V. Ratziu, P. Giral, and M. Munteanu et al. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia Aliment Pharmacol Ther 25 2007 207 218
19. D.E. Kleiner, E.M. Brunt, and M. Van Natta et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
20. S. Zelber-Sagi, D. Nitzan-Kaluski, and R. Goldsmith et al. Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study Hepatology 48 2008 1791 1798
21. S. Zelber-Sagi, D. Nitzan-Kaluski, and R. Goldsmith et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study J Hepatol 47 2007 711 717
22. R. Gore Diffuse liver disease R. Gore, M. Levine, I. Laufer, Textbook of gastrointestinal radiology 1994 Saunders Philadelphia 1968 2017
23. M. Webb, H. Yeshua, and S. Zelber-Sagi et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis AJR Am J Roentgenol 192 2009 909 914
24. M. Mancini, A. Prinster, and G. Annuzzi et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy Metabolism 58 2009 1724 1730
25. J.L. Martin-Rodriguez, J.P. Arrebola, and J.J. Jimenez-Moleon et al. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy Eur J Gastroenterol Hepatol 26 2014 88 94
26. E. Lopez-Garcia Coffee consumption and risk of chronic diseases: changing our views Am J Clin Nutr 95 2012 787 788
27. N.D. Freedman, Y. Park, and C.C. Abnet et al. Association of coffee drinking with total and cause-specific mortality N Engl J Med 366 2012 1891 1904
28. M.F. Abdelmalek, A. Suzuki, and C. Guy et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
29. C.O. Zein, A. Unalp, and R. Colvin et al. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease J Hepatol 54 2011 753 759
30. W. Dunn, A.J. Sanyal, and E.M. Brunt et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD) J Hepatol 57 2012 384 391
31. V. Lecoultre, G. Carrel, and L. Egli et al. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men Am J Clin Nutr 99 2014 268 275
32. S.G. Shim, D.W. Jun, and E.K. Kim et al. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model J Gastroenterol Hepatol 28 2013 1877 1884
33. P. Vitaglione, F. Morisco, and G. Mazzone et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins Hepatology 52 2010 1652 1661
34. F. Salomone, G. Li Volti, and P. Vitaglione et al. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease Transl Res 163 2014 593 602
35. F. Salamone, F. Galvano, and A. Marino Gammazza et al. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis Dig Liver Dis 44 2012 334 342
36. F. Salamone, G. Li Volti, and L. Titta et al. Moro orange juice prevents fatty liver in mice World J Gastroenterol 18 2012 3862 3868
37. T. Poynard, V. Ratziu, and F. Charlotte et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease BMC Gastroenterol 6 2006 34
38. G. Musso, R. Gambino, and M. Cassader et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 2011 617 649
39. T. Poynard, M. Munteanu, and O. Deckmyn et al. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population J Hepatol 57 2012 541 548
40. T. Poynard, P. Lebray, and P. Ingiliz et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) BMC Gastroenterol 10 2010 40
41. S. Jacqueminet, P. Lebray, and R. Morra et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes Clin Gastroenterol Hepatol 6 2008 828 831